Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)
Johnson & Johnson recorded quarterly Inventory Average of $14.4 billion in Q1 2026, up 1.54% quarter-over-quarter from $14.2 billion in Q4 2025, and up 14.62% year-over-year from $12.6 billion in Q1 2025.
Johnson & Johnson's Inventory Average history runs 18 years deep, the most recent figure standing at $14.4 billion for Q1 2026.
- In Q1 2026, Inventory Average rose 14.62% year-over-year to $14.4 billion; the TTM figure through Mar 2026 stood at $14.4 billion (up 14.62% YoY), while the FY2025 annual figure was $13.3 billion, up 12.74% from the prior year.
- Inventory Average came in at $14.4 billion for Q1 2026 at Johnson & Johnson, up from $14.2 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $14.4 billion in Q1 2026 to a low of $10.4 billion in Q1 2022.
- A 5-year average of $12.1 billion and a median of $11.9 billion in 2023 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average dropped 8.35% in 2024 and climbed 14.62% in 2026, its largest moves.
- Johnson & Johnson's Inventory Average stood at $11.6 billion in 2022, then declined by 3.17% to $11.2 billion in 2023, then rose by 11.92% to $12.5 billion in 2024, then rose by 13.14% to $14.2 billion in 2025, then advanced by 1.54% to $14.4 billion in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $14.4 billion, $14.2 billion, and $13.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 2.74 Bn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 14.14 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 14.39 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 5.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.72 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 7.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 14.39 Bn |
| Dec 28, 2025 | 14.17 Bn |
| Sep 28, 2025 | 13.78 Bn |
| Jun 29, 2025 | 13.04 Bn |
| Mar 30, 2025 | 12.55 Bn |
| Dec 29, 2024 | 12.52 Bn |
| Sep 29, 2024 | 12.39 Bn |
| Jun 30, 2024 | 11.78 Bn |
| Mar 31, 2024 | 11.28 Bn |
| Dec 31, 2023 | 11.19 Bn |
| Oct 1, 2023 | 12.04 Bn |
| Jul 2, 2023 | 12.85 Bn |
| Apr 2, 2023 | 11.54 Bn |
| Jan 1, 2023 | 10.97 Bn |
| Oct 2, 2022 | 11.56 Bn |
| Jul 3, 2022 | 11.21 Bn |
| Apr 3, 2022 | 10.69 Bn |
| Jan 2, 2022 | 10.39 Bn |
| Oct 3, 2021 | 10.24 Bn |
| Jul 4, 2021 | 10.03 Bn |
| Apr 4, 2021 | 9.65 Bn |
| Jan 3, 2021 | 9.47 Bn |
| Sep 27, 2020 | 9.51 Bn |
| Jun 28, 2020 | 9.15 Bn |
| Mar 29, 2020 | 8.94 Bn |
| Dec 29, 2019 | 9.10 Bn |
| Sep 29, 2019 | 9.22 Bn |
| Jun 30, 2019 | 9.17 Bn |
| Mar 31, 2019 | 8.84 Bn |
| Dec 30, 2018 | 8.64 Bn |
| Sep 30, 2018 | 8.74 Bn |
| Jul 1, 2018 | 8.91 Bn |
| Apr 1, 2018 | 8.89 Bn |
| Dec 31, 2017 | 9.14 Bn |
| Oct 1, 2017 | 9.61 Bn |
| Jul 2, 2017 | 9.29 Bn |
| Apr 2, 2017 | 8.51 Bn |
| Jan 1, 2017 | 8.32 Bn |
| Oct 2, 2016 | 8.51 Bn |
| Jul 3, 2016 | 8.35 Bn |
| Apr 3, 2016 | 8.11 Bn |
| Jan 3, 2016 | 8.13 Bn |
| Sep 27, 2015 | 8.25 Bn |
| Jun 28, 2015 | 8.19 Bn |
| Mar 29, 2015 | 8.13 Bn |
| Dec 28, 2014 | 8.30 Bn |
| Sep 28, 2014 | 8.29 Bn |
| Jun 29, 2014 | 8.08 Bn |
| Mar 30, 2014 | 7.94 Bn |
| Dec 29, 2013 | 8.00 Bn |
| Sep 29, 2013 | 7.97 Bn |
| Jun 30, 2013 | 7.76 Bn |
| Mar 31, 2013 | 7.59 Bn |
| Dec 30, 2012 | 7.65 Bn |
| Sep 30, 2012 | 7.75 Bn |
| Jul 1, 2012 | 7.25 Bn |
| Apr 1, 2012 | 6.54 Bn |
| Jan 1, 2012 | 6.36 Bn |
| Oct 2, 2011 | 6.42 Bn |
| Jul 3, 2011 | 6.31 Bn |
| Apr 3, 2011 | 5.79 Bn |
| Jan 2, 2011 | 5.39 Bn |
| Oct 3, 2010 | 5.24 Bn |
| Jul 4, 2010 | 5.19 Bn |
| Apr 4, 2010 | 5.24 Bn |
| Jan 3, 2010 | 5.37 Bn |
| Sep 27, 2009 | 5.52 Bn |